Notes / Company

Mahamaya Lifesciences Ltd.

MAHALIFE BSE 544611 ISIN INE0U9D01019 Agrochemicals

Fundamentals

Market cap: ₹393 cr
P/E: 23.77×
ROE: 26.19%
Debt / equity: 1.18
52-week range: 111.00 — 205.05

Research on Tijori Finance

The timeline — 1 note on Mahamaya Lifesciences Ltd.

May 2026

26 May 26 · 1:14 PM IST Brief

Brief · Earnings · Micro cap

Mahamaya Lifesciences releases FY26 audited results

The company confirms previously disclosed annual figures of ₹328.87 crore in revenue and ₹16.52 crore in profit.

Verify on exchange BSE filings for MAHALIFE NSE filings for MAHALIFE Tijori Finance company page